Efficacy of the combination treatment of epinastine hydrochloride 0.1% and bromfenac sodium ophthalmic solution for allergic conjunctivitis.

Efficacy of the combination treatment of epinastine hydrochloride 0.1% and bromfenac sodium ophthalmic solution for allergic conjunctivitis. - Efficacy of the combination treatment of epinastine hydrochloride 0.1% and bromfenac sodium ophthalmic solution for allergic conjunctivitis.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000043696

Enrollment

Registered

2021-03-29

Start date

2021-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

conjunctivitis

Interventions

The patients are treated with epinastine hydrochloride 0.1% twice a day, and bromfenac sodium ophthalmic solution is concomitantly administered twice a day in one eye and artificial tears is administe

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: allergic conjunctivitis

Exclusion criteria

Exclusion criteria: conjunctivitis with Stevens-Johnson syndrome and/or proliferative atopic keratoconjunctivitis contact lens wearers eyes with pretreatment

Design outcomes

Primary

Measure	Time frame
The improvement rate in conjunctivitis findings when two types of eye drops are uesd together	—

Secondary

Measure	Time frame
The improvement rate in subjective symptoms when two types of eye drops are uesd together	—

Countries

Japan

Contacts

Public ContactAsako Kodama

Eiju General Hospital Department of ophthalmology

asa-chanyy_4747@kmh.biglobe.ne.jp81338338381

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026